We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROST icon
26
Ross Stores
ROST
$76.6B
$260M 0.55%
2,453,123
+1,090,520
+80% +$122M
ATVI
27
DELISTED
Activision Blizzard
ATVI
$259M 0.55%
3,025,164
-696,409
-19% -$54.1M
ELV icon
28
Elevance Health
ELV
$81.9B
$251M 0.53%
545,665
+179,016
+49% +$85.2M
SPGI icon
29
S&P Global
SPGI
$126B
$243M 0.52%
704,102
+193,435
+38% +$68.1M
BAX icon
30
Baxter International
BAX
$11.6B
$243M 0.52%
5,979,786
+3,271,267
+121% +$139M
LLY icon
31
Eli Lilly
LLY
$1.07T
$237M 0.5%
689,096
+553,096
+407% +$187M
NKE icon
32
Nike
NKE
$61.9B
$225M 0.48%
1,832,123
-1,012,921
-36% -$125M
NEE icon
33
NextEra Energy
NEE
$187B
$225M 0.48%
2,913,776
+2,046,716
+236% +$157M
UNH icon
34
UnitedHealth
UNH
$382B
$219M 0.46%
463,007
+457,936
+9,030% +$221M
BSX icon
35
Boston Scientific
BSX
$65.8B
$212M 0.45%
4,232,766
-1,589,247
-27% -$74.9M
GOOGL icon
36
Alphabet (Google) Class A
GOOGL
$3.91T
$208M 0.44%
2,003,293
+47,667
+2% +$4.57M
MCO icon
37
Moody's
MCO
$81.7B
$202M 0.43%
661,007
+250,987
+61% +$75.8M
MA icon
38
Mastercard
MA
$477B
$199M 0.42%
548,352
+185,900
+51% +$67.5M
CVS icon
39
CVS Health
CVS
$137B
$196M 0.42%
2,638,793
+2,485,840
+1,625% +$208M
CRL icon
40
Charles River Laboratories
CRL
$10.9B
$193M 0.41%
954,914
+80,141
+9% +$18.2M
CROX icon
41
Crocs
CROX
$6.69B
$191M 0.41%
1,509,851
-517,481
-26% -$62.5M
LIN icon
42
Linde
LIN
$237B
$188M 0.4%
528,996
+467,184
+756% +$156M
QQQ icon
43
PUT
Invesco QQQ Trust
QQQ
$455B
$188M 0.4%
584,700
+22,500
+4% +$6.64M
ROKU icon
44
Roku
ROKU
$21.1B
$180M 0.38%
2,729,534
+765,638
+39% +$44.8M
CBOE icon
45
Cboe Global Markets
CBOE
$29.8B
$179M 0.38%
1,333,842
+337,665
+34% +$42.4M
TSLA icon
46
Tesla
TSLA
$1.24T
$179M 0.38%
860,408
+574,279
+201% +$100M
C icon
47
Citigroup
C
$222B
$171M 0.36%
3,656,104
-2,662,250
-42% -$131M
ALC icon
48
Alcon
ALC
$33.1B
$164M 0.35%
2,311,596
+1,328,071
+135% +$94.5M
FTNT icon
49
Fortinet
FTNT
$112B
$163M 0.35%
2,455,547
-52,131
-2% -$2.96M
GOOG icon
50
Alphabet (Google) Class C
GOOG
$3.9T
$163M 0.35%
1,565,060
+609,900
+64% +$58.9M
1
2
3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.